Search - tctmd.com

Displaying 1 - 3 of 3

Sort: Relevancy | Date

Progression to Overt or Silent CAD in Asymptomatic Patients with Diabetes at High Coronary Risk

Presentation

Progression to Overt or Silent CAD in Asymptomatic Patients with Diabetes at High Coronary Risk

Presenter: Michael J. Zellweger

September 25, 2014

Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes

Presentation

Effect of Aleglitazar on Cardiovascular Outcomes after ACS in Patients with Type 2 Diabetes

Presenter: A. Michael Lincoff

April 04, 2014

Optimizing the Diabetic Formulary: Managing the Triad of Glycemic Control, Blood Pressure, and Hyperlipidemia

Presentation TCT 2012

Optimizing the Diabetic Formulary: Managing the Triad of Glycemic Control, Blood Pressure, and Hyperlipidemia

Presenter: Michael Farkouh

October 26, 2012

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.